Latest filing published 10 Sept 2026 for 아이엠바이오로직스.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 신한벤처투자 across 2 companies, led by 아이엠바이오로직스 and 메쥬. The record holds 3 filings, for trades running from 20 March 2026 to 10 September 2026.
Every open-market trade on record is a purchase: 2 purchases, and no sale. The totals do not cover 2 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 10 September 2026 with a transaction in 아이엠바이오로직스. The last purchase on record was published on 1 April 2026, which is 207 days ago. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations